Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

Strategic research and development collaboration in RAS/MAPK-driven cancers announced

Strategic research and development collaboration in RAS/MAPK-driven cancers announced

AI model that reduces cost and time and increasing accuracy of cancer diagnosis

AI model that reduces cost and time and increasing accuracy of cancer diagnosis

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for HER2-mutant non-small cell lung cancer

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for HER2-mutant non-small cell lung cancer

FDA approves capmatinib for metastatic non-small cell lung cancer

FDA approves capmatinib for metastatic non-small cell lung cancer

Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer

Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced...

WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers

WCLC 2022: Chinese researchers develop lung cancer risk prediction nomogram for female non - smokers

WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab + chemotherapy in mNSCLC

WCLC 2022: Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON: Durvalumab ± tremelimumab +...

WCLC 2022: Sexual dysfunction high among women with lung cancer

WCLC 2022: Sexual dysfunction high among women with lung cancer

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...

More from ecancer